3, normalization of oxygentransport indicators was evident, particularly in the D + S group
A new large-scale study from Truveta and collaborators from Providence, Johns Hopkins, Duke University, and more suggests that glucagon-like peptide-1 receptor agonists (GLP-1 RAs)semaglutide and tirzepatidemay have another powerful benefit: reducing alcohol-related hospitalizations in people with alcohol use disorder (AUD)
Reinventing a familiar molecule Veradermics, meanwhile, is taking a more formulation-driven approach
TMAOs role in neurological illnesses, such as Alzheimers, and cancer, particularly colorectal cancer, is becoming more widely acknowledged
The combination creates a 7-10 day window of worsened CSF dynamics
Lifestyle changes weight management, exercise, stress reduction are the foundation of prevention and treatment